Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

46.67
Delayed Data
As of Aug 28
 +0.41 / +0.89%
Today’s Change
15.10
Today|||52-Week Range
56.18
+108.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues77.4M53.1M2.9M0.00
 
 
 
 
Depreciation And Amortization694.0K657.0K671.0K827.0K
 
 
 
 
 
 
Operating ExpensesGross Income76.7M--2.2M-827.0K
 
 
 
 
General Expenses41.7M49.9M51.9M63.6M
 
 
 
 
 
Other Operating Expenses0.001.1M0.000.00
 
 
Research And Development31.0M37.2M39.2M46.4M
 
 
 
 
 
Total Operating Expenses42.4M51.7M52.6M64.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income35.0M1.4M-49.7M-64.4M
 
 
 
 
 
Extraordinary Charge-1.1M0.00----
 
 
Other Expenses3.2M3.1M3.2M3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income37.6M5.0M-46.1M-60.5M
 
 
 
 
 
Net Income37.6M5.0M-46.1M-60.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.2M65.6M67.0M74.6M
 
 
 
 
 
Shares To Calculate EPS Diluted56.3M66.9M67.0M74.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.67$0.08-$0.69-$0.81
 
 
 
 
 
EPS Diluted$0.67$0.08-$0.69-$0.81